Cambridge Biotechnology Overview

  • Year Founded
  • 2001

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 25

Employees

  • Latest Deal Type
  • M&A

  • Investors
  • 1

Cambridge Biotechnology General Information

Description

Developer of drugs designed for the treatment of clinical obesity. The company develops lead compounds for diseases with large medical needs using proprietary technologies.

Contact Information

Formerly Known As
Awa 122 Limited
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • Building 250
  • Babraham Research Campus
  • Cambridge CB22 3AT
  • England, United Kingdom
+44 01223
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Acquirer
Vertical(s)
Corporate Office
  • Building 250
  • Babraham Research Campus
  • Cambridge CB22 3AT
  • England, United Kingdom
+44 01223

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Cambridge Biotechnology Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 21-Mar-2005 Completed Product Development
3. Early Stage VC 30-Sep-2004 Completed Product Development
2. Early Stage VC (Series A) 01-Jul-2002 $8.94M $8.94M Completed Product Development
1. University Spin-Out 01-May-2001 Completed Startup
To view Cambridge Biotechnology’s complete valuation and funding history, request access »

Cambridge Biotechnology Patents

Cambridge Biotechnology Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-0420615-D0 Therapeutic compounds Inactive 16-Sep-2004
GB-0420063-D0 Therapeutic compounds Inactive 09-Sep-2004
GB-0419718-D0 Therapeutic compounds Inactive 06-Sep-2004
GB-0413627-D0 Analgesics Inactive 18-Jun-2004
GB-0412259-D0 Analgesics Inactive 02-Jun-2004
To view Cambridge Biotechnology’s complete patent history, request access »

Cambridge Biotechnology Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Cambridge Biotechnology Former Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Avlar BioVentures Venture Capital Minority
Cambridge Gateway Fund Venture Capital Minority
Excalibur Group Holdings Corporation Minority
Johnson & Johnson JJDC Corporate Venture Capital Minority
NVM Private Equity PE/Buyout Minority
To view Cambridge Biotechnology’s complete investors history, request access »

Cambridge Biotechnology FAQs

  • When was Cambridge Biotechnology founded?

    Cambridge Biotechnology was founded in 2001.

  • Where is Cambridge Biotechnology headquartered?

    Cambridge Biotechnology is headquartered in Cambridge, United Kingdom.

  • What is the size of Cambridge Biotechnology?

    Cambridge Biotechnology has 25 total employees.

  • What industry is Cambridge Biotechnology in?

    Cambridge Biotechnology’s primary industry is Drug Discovery.

  • Is Cambridge Biotechnology a private or public company?

    Cambridge Biotechnology is a Private company.

  • What is Cambridge Biotechnology’s current revenue?

    The current revenue for Cambridge Biotechnology is .

  • How much funding has Cambridge Biotechnology raised over time?

    Cambridge Biotechnology has raised $15.8M.

  • Who are Cambridge Biotechnology’s investors?

    Avlar BioVentures, Cambridge Gateway Fund, Excalibur Group Holdings, Johnson & Johnson JJDC, and NVM Private Equity have invested in Cambridge Biotechnology.

  • When was Cambridge Biotechnology acquired?

    Cambridge Biotechnology was acquired on 21-Mar-2005.

  • Who acquired Cambridge Biotechnology?

    Cambridge Biotechnology was acquired by Biovitrum.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process